Literature DB >> 21203766

Role of biomarkers in assessment of early infarct size after successful p-PCI for STEMI.

Gert Klug1, Agnes Mayr, Johannes Mair, Michael Schocke, Michael Nocker, Thomas Trieb, Werner Jaschke, Otmar Pachinger, Bernhard Metzler.   

Abstract

OBJECTIVE: The aim of the study was to find out if single time point and estimated cumulative release of cardiac troponin T (cTnT) and creatine kinase (CK) correlate with early infarct size and left ventricular function measured by cardiac magnetic resonance (CMR).
METHODS: CMR and serial CK and cTnT measurements were performed in 103 patients (85 male, mean age 55.8 ± 12.1 years) within at least 8 days (3.1 ± 1.5 days) after first acute myocardial infarction and successful primary percutaneous coronary interventions. Infarct size was determined on delayed gadolinium-enhanced phase-sensitive IR-SSFP CMR sequences. Single time point, peak and cumulative cardiac protein release were correlated with infarct size.
RESULTS: All single time point, peak and estimated cumulative release of CK and cTnT values except on admission showed significant correlations with infarct size. Among single time point values, cTnT after 96 h (cTnT(96); r = 0.680, p < 0.001) and CK after 24 h (CK(24); r = 0.699, p < 0.001) showed the closest correlations with infarct size. Peak CK and cTnT levels correlated only slightly better than single time point values (r = 0.703 and 0.688, p < 0.001), whereas cumulative release values did not show closer correlations than single point values. Receiver-operator characteristics analysis showed that cTnT(96) and CK(24) detected large infarct areas (>16.8 g) and decreased left ventricular function (EF < 40%) with high sensitivity and specificity.
CONCLUSION: Both single time point cTnT concentrations and CK activities correlate well with infarct size early after primary PCI for STEMI. Cardiac TnT levels determined 3-4 days after revascularization for acute myocardial infarction allow for a good estimation of acute infarct size as well as an approximation of LV function and morphology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21203766     DOI: 10.1007/s00392-010-0273-0

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  40 in total

1.  The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes.

Authors:  Stefano Savonitto; Christopher B Granger; Diego Ardissino; Laura Gardner; Claudio Cavallini; Marcello Galvani; Filippo Ottani; Harvey D White; Paul W Armstrong; E Magnus Ohman; Karen S Pieper; Robert M Califf; Eric J Topol
Journal:  J Am Coll Cardiol       Date:  2002-01-02       Impact factor: 24.094

2.  Measurement of troponin I 48 h after admission as a tool to rule out impaired left ventricular function in patients with a first myocardial infarction.

Authors:  Mauro Panteghini; Graziella Bonetti; Franca Pagani; Francesca Stefini; Raffaele Giubbini; Claudio Cuccia
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

3.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

4.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

5.  Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months.

Authors:  Ellen Bøhmer; Pavel Hoffmann; Michael Abdelnoor; Ingebjørg Seljeflot; Sigrun Halvorsen
Journal:  Cardiology       Date:  2009-02-14       Impact factor: 1.869

6.  Estimation of acute myocardial infarct size in man by serum CK-MB measurements.

Authors:  P Grande; B F Hansen; C Christiansen; J Naestoft
Journal:  Circulation       Date:  1982-04       Impact factor: 29.690

7.  Plasma cardiac troponin T closely correlates with infarct size in a mouse model of acute myocardial infarction.

Authors:  Bernhard Metzler; Angelika Hammerer-Lercher; Johannes Jehle; Hermann Dietrich; Otmar Pachinger; Qingbo Xu; Johannes Mair
Journal:  Clin Chim Acta       Date:  2002-11       Impact factor: 3.786

8.  Gender-related outcome following percutaneous coronary intervention for ST-elevation myocardial infarction: data from the Austrian acute PCI registry.

Authors:  Alois Suessenbacher; Jakob Doerler; Hannes Alber; Josef Aichinger; Johann Altenberger; Werner Benzer; Guenter Christ; Sebastian Globits; Kurt Huber; Ronald Karnik; Georg Norman; Peter Siostrzonek; Gerald Zenker; Otmar Pachinger; Franz Weidinger
Journal:  EuroIntervention       Date:  2008-08       Impact factor: 6.534

9.  Comparison of Troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty.

Authors:  Dan Tzivoni; Daniel Koukoui; Victor Guetta; Lena Novack; Graham Cowing
Journal:  Am J Cardiol       Date:  2008-01-14       Impact factor: 2.778

10.  Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention.

Authors:  Jürgen Haase; Rusen Bayar; Matthias Hackenbroch; Hans Störger; Manfred Hofmann; Claus-Eberhard Schwarz; Harald Reinemer; Franz Schwarz; Johannes Ruef; Torsten Sommer
Journal:  J Interv Cardiol       Date:  2004-12       Impact factor: 2.279

View more
  13 in total

1.  Relationship and prognostic value of microvascular obstruction and infarct size in ST-elevation myocardial infarction as visualized by magnetic resonance imaging.

Authors:  Suzanne de Waha; Steffen Desch; Ingo Eitel; Georg Fuernau; Philipp Lurz; Anja Leuschner; Matthias Grothoff; Matthias Gutberlet; Gerhard Schuler; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2012-06       Impact factor: 5.460

2.  Corin as novel biomarker for myocardial infarction.

Authors:  Hans-Josef Feistritzer; Bernhard Metzler
Journal:  Ann Transl Med       Date:  2016-10

3.  The role of circulating microRNAs in acute coronary syndromes: ready for prime time?

Authors:  Gert Klug; Bernhard Metzler
Journal:  Ann Transl Med       Date:  2016-12

4.  Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial.

Authors:  José M Dizon; Sorin J Brener; Akiko Maehara; Bernard Witzenbichler; Angelo Biviano; Jacek Godlewski; Helen Parise; Jan-Henk Dambrink; Roxana Mehran; C Michael Gibson; Gregg W Stone
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-10-03

5.  Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction.

Authors:  Hossein Khalili; Azita Hajhossein Talasaz; Mojtaba Salarifar
Journal:  Clin Res Cardiol       Date:  2011-12-11       Impact factor: 5.460

6.  TNF-α, myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention.

Authors:  Eva S Kehmeier; Wolfgang Lepper; Martina Kropp; Christian Heiss; Ulrike Hendgen-Cotta; Jan Balzer; Mirja Neizel; Christian Meyer; Marc W Merx; Pablo E Verde; Christian Ohmann; Gerd Heusch; Malte Kelm; Tienush Rassaf
Journal:  Clin Res Cardiol       Date:  2012-05-06       Impact factor: 5.460

7.  Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold.

Authors:  Jens Wiebe; Helge Möllmann; Astrid Most; Oliver Dörr; Kay Weipert; Johannes Rixe; Christoph Liebetrau; Albrecht Elsässer; Stephan Achenbach; Christian Hamm; Holger Nef
Journal:  Clin Res Cardiol       Date:  2013-10-18       Impact factor: 5.460

8.  Prognostic value at 5 years of microvascular obstruction after acute myocardial infarction assessed by cardiovascular magnetic resonance.

Authors:  Gert Klug; Agnes Mayr; Sonja Schenk; Regina Esterhammer; Michael Schocke; Michael Nocker; Werner Jaschke; Otmar Pachinger; Bernhard Metzler
Journal:  J Cardiovasc Magn Reson       Date:  2012-07-12       Impact factor: 5.364

9.  Comparison of an oscillometric method with cardiac magnetic resonance for the analysis of aortic pulse wave velocity.

Authors:  Hans-Josef Feistritzer; Sebastian J Reinstadler; Gert Klug; Christian Kremser; Benjamin Seidner; Regina Esterhammer; Michael F Schocke; Wolfgang-Michael Franz; Bernhard Metzler
Journal:  PLoS One       Date:  2015-01-22       Impact factor: 3.240

Review 10.  Copeptin testing in acute myocardial infarction: ready for routine use?

Authors:  Sebastian Johannes Reinstadler; Gert Klug; Hans-Josef Feistritzer; Bernhard Metzler; Johannes Mair
Journal:  Dis Markers       Date:  2015-04-16       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.